CLINICAL_TRIALS trial_result · 2021-06-01

Clinical Trial Update: Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women [Phase 3]

Phase 3 trial results for FE 999049 in controlled ovarian stimulation in Pan-Asian women have been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Ferring Pharmaceuticals | Conditions: Controlled Ovarian Simulation | Phase 3 | Status: COMPLETED | Results posted: 2021-06-01